Advertisement
Screener

ZYMEWORKS INC. (ZYME) Cash Flow Breakdown

ZYMEWORKS INC. Cash Flow Breakdown

Cash flow breakdown shows where ZYMEWORKS INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $33.01M went out.
  • Fiscal year ended 2025-12-31: from investing, $26.66M came in.
  • Fiscal year ended 2025-12-31: from financing, $18.56M went out.
  • Fiscal year ended 2025-12-31: change in cash, $24.95M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2025-12-31-$33.01M$26.66M-$41.70M$0.00$23.14M*-$24.95M
2024-12-31-$110.06M$38.76M-$30.05M$0.00$9.61M*-$91.45M
2023-12-31-$118.32M-$207.25M$0.00$26.23M$55.63M*-$243.35M
2022-12-31$144.11M-$53.85M$0.00$107.53M$1.05M*$199.04M
2021-12-31-$192.45M$144.60M$0.00$8.01M*-$40.17M
2020-12-31-$151.40M-$43.44M$300.91M$8.07M*$113.58M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldNot split outChange in cash
2026-06-30-$31.95M*$17.07M*-$51.95M*$2.89M*-$958.00K*
2026-03-31-$45.72M$69.96M-$76.15M$8.72M$246.22M*$203.13M
2025-12-31-$10.26M*$5.37M*-$25.48M*$6.83M*
2025-09-30-$31.41M*$368.00K*-$16.22M*$7.92M*$5.84M*
2025-06-30$12.07M*$8.74M*$0.00*$1.38M*
2025-03-31-$3.41M$12.18M$0.00$772.00K$544.00K*$10.10M
2024-12-31-$41.51M*-$6.21M*-$9.43M*$0.00*$785.00K*
2024-09-30-$5.88M*$72.26M*$0.00*-$14.98M*
2024-06-30-$24.99M*-$19.97M*$1.13M*
2024-03-31-$37.67M-$7.32M$1.74M-$42.74M
2023-12-31$13.93M*-$1.34M*$0.00*$0.00*$50.63M*
2023-09-30-$42.67M*-$7.02M*$0.00*$1.90M*
2023-06-30-$6.40M*-$60.67M*$26.23M*$1.37M*
2023-03-31-$83.19M-$138.22M$0.00$1.74M*-$219.33M
2022-12-31$327.36M*-$22.07M*$0.00*
2022-09-30-$73.02M*-$30.43M*$0.00*$628.00K*
2022-06-30-$54.82M*-$21.93M*-$186.00K*
2022-03-31-$55.41M$20.57M$107.72M$890.00K*$73.65M
2021-12-31-$50.51M*-$1.86M*$689.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Septerna, Inc. (SEPN)United States$1.783B-63.01
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Xencor Inc (XNCR)United States$1.776B-7.33